Skip to main content

Market Overview

Oculus Shares Spike Higher Following WebMD Interview With President Obama On Antibiotic Resistance

Share:

Shares of Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) spiked up Friday morning amid the publishing of an interview with President Obama on WebMD.

President Obama said, "Antibiotic resistance is one of the most pressing public health issues facing the world today. It causes tens of thousands of deaths and millions of illnesses every year – just in the United States alone."

The interview coincided with Obama administration releasing its National Action Plan for Combating Antibiotic-Resistant Bacteria on Friday.

According to the President, the plan "addresses the problem from multiple angles at once: from stopping the spread of drug resistance right now through the more judicious use of antibiotics, to developing new antibiotics that will save and improve lives in the future, to working with partners worldwide to make sure that while we're fighting drug resistance here in the United States, it isn't gaining ground somewhere else in the world. And we're working to significantly reduce the use of antibiotics in livestock and poultry, too."

Part of the plan included doubling the budget for investments in combating and preventing antibiotic resistance.

President Obama concluded that antibiotics were "vital to our national security," when it came to saving lives of service members in battle, preventing widespread infections and defending against bio-terrorism.

After spiking to $0.845, Oculus Innovative Sciences gave back its gains and recently traded unchanged at $0.810.

 

Related Articles (OCLS)

View Comments and Join the Discussion!

Posted-In: President Obama webMDNews

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com